Correction: "Tandem phosphorylation of serines 221 and 318 by protein kinase Cd coordinates mRNA binding and nucleocytoplasmic shuttling of HuR" [30, 6, (1397-1410), 2010] DOI: https://doi.org/10.1128/MCB.01373-09;Tandem phosphorylation of serines 221 and 318 by protein kinase Cδ coordinates mRNA binding and nucleocytoplasmic shuttling of HuR

Molecular and Cellular Biology

Volumn 30, Issue 6, 2010, Pages 1397-1410

  Doller, Anke ^a   Schlepckow, Kai ^b   Schwalbe, Harald ^b   Pfeilschifter, Josef ^a   Eberhardt, Wolfgang ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CYCLIN A; CYCLIN D1; CYCLOOXYGENASE 2; HUR PROTEIN; MESSENGER RNA; PROTEIN KINASE C DELTA; SERINE;

ARTICLE; CYTOPLASM; GENE MUTATION; HUMAN; HUMAN CELL; MESANGIUM CELL; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RNA BINDING; WOUND HEALING;

EID: 77749334696     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00151-17     Document Type: Erratum

References (61)

1. Abdelmohsen, K., R. Pullmann, Jr., A. Lal, H. H. Kim, S. Galban, X. Yang, J. D. Blethrow, M. Walker, J. Shubert, D. A. Gillespie, H. Furneaux, and M. Gorospe. 2007. Phosphorylation of HuR by Chk2 regulates SIRT1 expression. Mol. Cell 25:543-557.
2. Abdelmohsen, K., Y. Kuwano, H. H. Kim, and M. Gorospe. 2008. Posttranscriptional gene regulation by RNA-binding proteins during oxidative stress: implications for cellular senescence. Biol. Chem. 389:243-255.
3. Abdelmohsen, K., S. Srikantan, Y. Kuwano, and M. Gorospe. 2008. miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels. Proc. Natl. Acad. Sci. U. S. A. 105:20297-20302.
4. Abdelmohsen, K., S. Srikantan, X. Yang, A. Lal, H. H. Kim, Y. Kuwano, S. Galban, K. G. Becker, D. Kamara, R. de Cabo, and M. Gorospe. 2009. Ubiquitin-mediated proteolysis of HuR by heat shock. EMBO J. 28:1271-1282.
5. Akool, el-S., H. Kleinert, F. M. Hamada, M. H. Abdelwahab, U. Förstermann, J. Pfeilschifter, and W. Eberhardt. 2003. Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR. Mol. Cell. Biol. 23:4901-4916.
6. Braun-Dullaeus, R. C., M. J. Mann, A. Ziegler, H. E. von der Leyen, and V. J. Dzau. 1999. A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy. J. Clin. Invest. 104:815-823.
7. Brennan, C. M., I. E. Gallouzi, and J. A. Steitz. 2000. Protein ligands to HuR modulate its interaction with target mRNAs in vivo. J. Cell Biol. 151:1-14.
8. Chen, C. Y., and A. B. Shyu. 1995. AU-rich elements: characterization and importance in mRNA degradation. Trends Biochem. Sci. 20:465-470.
9. Chen, C. Y., N. Xu, and A. B. Shyu. 2002. Highly selective actions of HuR in antagonizing AU-rich element-mediated mRNA destabilization. Mol. Cell. Biol. 22:7268-7278.
10. Denkert, C., W. Weichert, S. Pest, I. Koch, D. Licht, M. Kobel, A. Reles, J. Sehouli, M. Dietel, and S. Hauptmann. 2004. Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression. Cancer Res. 64:189-195.
11. Denkert, C., W. Weichert, K. J. Winzer, B. M. Muller, A. Noske, S. Niesporek, G. Kristiansen, H. Guski, M. Dietel, and S. Hauptmann. 2004. Expression of the ELAV-like protein HuR is associated with higher tumor grade and increased cyclooxygenase-2 expression in human breast carcinoma. Clin. Cancer Res. 10:5580-5586.
12. Díaz-Moreno, I., D. Hollingworth, T. A. Frenkiel, G. Kelly, S. Martin, S. Howell, M. García-Mayoral, R. Gherzi, P. Briata, and A. Ramos. 2009. Phosphorylation-mediated unfolding of a KH domain regulates KSRP localization via 14-3-3 binding. Nat. Struct. Mol. Biol. 16:238-246.
13. Dixon, D. A., N. D. Tolley, P. H. King, L. B. Nabors, T. M. McIntyre, G. A. Zimmerman, and S. M. Prescott. 2001. Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells. J. Clin. Invest. 108:1657-1665.
14. Doller, A., A. Huwiler, R. Müller, H. H. Radeke, J. Pfeilschifter, and W. Eberhardt. 2007. Protein kinase C α-dependent phosphorylation of the mRNA-stabilizing factor HuR: implications for posttranscriptional regulation of cyclooxygenase-2. Mol. Biol. Cell 18:2137-2148.
15. Doller, A., J. Pfeilschifter, and W. Eberhardt. 2008. Signalling pathways regulating nucleo-cytoplasmic shuttling of the mRNA-binding protein HuR. Cell. Signal. 20:2165-2173.
16. Doller, A., el-S. Akool, A. Huwiler, R. Müller, H. H. Radeke, J. Pfeilschifter, and W. Eberhardt. 2008. Posttranslational modification of the AU-rich element binding protein HuR by protein kinase Cδ elicits angiotensin II-induced stabilization and nuclear export of cyclooxygenase 2 mRNA. Mol. Cell. Biol. 28:2608-2625.
17. Doller, A., S. Gauer, E. Sobkowiak, H. Geiger, J. Pfeilschifter, and W. Eberhardt. 2009. Angiotensin II induces renal plasminogen activator inhibitor-1 and cyclooxygenase-2 expression post-transcriptionally via activation of the mRNA-stabilizing factor human-antigen R. Am. J. Pathol. 174:1252-1263.
18. Eberhardt, W., M. Schulze, C. Engels, E. Klasmeier, and J. Pfeilschifter. 2002. Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-κB and Ets transcription factors. Mol. Endocrinol. 6:1752-1766.
19. Fan, X. C., and J. A. Steitz. 1998. Overexpression of HuR, a nuclearcytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs. EMBO J. 17:3448-3460.
20. Fan, X. C., and J. A. Steitz. 1998. HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc. Natl. Acad. Sci. U. S. A. 95:15293- 15298.
21. Fialcowitz-White, E. J., B. Y. Brewer, J. D. Ballin, C. D. Willis, E. A. Toth, and G. M. Wilson. 2007. Specific protein domains mediate cooperative assembly of HuR oligomers on AU-rich mRNA-destabilizing sequences. J. Biol. Chem. 282:20948-20959.
22. García-Martínez, J., A. Aranda, and J. E. Pérez-Ortín. 2004. Genomic run-on evaluates transcription rates for all yeast genes and identifies gene regulatory mechanisms. Mol. Cell 15:303-313.
23. Geiges, D., T. Meyer, B. Marte, M. Vanek, G. Weissgerber, S. Stabel, J. Pfeilschifter, D. Fabbro, and A. Huwiler. 1997. Activation of protein kinase C subtypes alpha, gamma, delta, epsilon, zeta, and eta by tumor-promoting and nontumor-promoting agents. Biochem. Pharmacol. 53:865-875.
24. Gherzi, R., M. Trabucchi, M. Ponassi, T. Ruggiero, G. Corte, C. Moroni, C. Y. Chen, K. S. Khabar, J. S. Andersen, and P. Briata. 2006. The RNA-binding protein KSRP promotes decay of beta-catenin mRNA and is inactivated by PI3K-AKT signaling. PLoS Biol. 5:e5.
25. Güttinger, S., P. Mühlhäusser, R. Koller-Eichhorn, J. Brennecke, and U. Kutay. 2004. Transportin2 functions as importin and mediates nuclear import of HuR. Proc. Natl. Acad. Sci. U. S. A. 101:2918-2923.
26. He, C., and R. Schneider. 2006. 14-3-3sigma is a p37 AUF1-binding protein that facilitates AUF1 transport and AU-rich mRNA decay. EMBO J. 25: 3823-3831.
27. Heinonen, M., P. Bono, K. Narko, S. H. Chang, J. Lundin, H. Joensuu, H. Furneaux, T. Hla, C. Haglund, and A. Ristimäki. 2005. Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res. 65:2157-2161.
28. Hollams, E. M., K. M. Giles, A. M. Thomson, and P. J. Leedman. 2002. mRNA stability and the control of gene expression: implications for human disease. Neurochem. Res. 27:957-980.
29. Huwiler, A., S. Stabel, D. Fabbro, and J. Pfeilschifter. 1995. Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: comparison of hypertrophic and hyperplastic agonists. Biochem. J. 305:777-784.
30. Johnson, B. A., J. R. Stehn, M. B. Yaffe, and T. K. Blackwell. 2002. Cytoplasmic localization of tristetraprolin involves 14-3-3-dependent and -independent mechanisms. J. Biol. Chem. 277:18029-18036.
31. Keene, J. D., and S. A. Tenenbaum. 2002. Eukaryotic mRNPs may represent posttranscriptional operons. Mol. Cell 9:1161-1167.
32. Keene, J. D. 1999. Why is Hu where? Shuttling of early-response-gene messenger RNA subsets. Proc. Natl. Acad. Sci. U. S. A. 96:5-7.
33. Kim, H. H., K. Abdelmohsen, A. Lal, R. Jr. Pullmann, X. Yang, S. Galban, S. Srikantan, J. L. Martindale, J. Blethrow, K. M. Shokat, and M. Gorospe. 2008. Nuclear HuR accumulation through phosphorylation by Cdk1. Genes Dev. 22:1804-1815.
34. Kim, H. H., X. Yang, Y. Kuwano, and M. Gorospe. 2008. Modification at HuR(S242) alters HuR localization and proliferative influence. Cell Cycle 7:3371-3377.
35. Kim, H. H., and M. Gorospe. 2008. Phosphorylated HuR shuttles in cycles. Cell Cycle 7:3124-3126.
36. Kloss, S., H. Furneaux, and A. Mülsch. 2003. Post-transcriptional regulation of soluble guanylyl cyclase expression in rat aorta. J. Biol. Chem. 278:2377-2383.
37. Li, H., S. Park, B. Kilburn, M. A. Jelinek, A. Henschen-Edman, D. W. Aswad, M. R. Stallcup, and I. A. Laird-Offringa. 2002. Lipopolysaccharide- induced methylation of HuR, an mRNA-stabilizing protein, by CARM1. Coactivator-associated arginine methyltransferase. J. Biol. Chem. 277:44623-44630.
38. Li, Z., C. Wang, G. C. Prendergast, and R. G. Pestell. 2006. Cyclin D1 functions in cell migration. Cell Cycle 5:2440-2442.
39. Lin, S., W. Wang, G. M. Wilson, X. Yang, G. Brewer, N. J. Holbrook, and M. Gorospe. 2000. Down-regulation of cyclin D1 expression by prostaglandin A(2) is mediated by enhanced cyclin D1 mRNA turnover. Mol. Cell. Biol. 20:7903-7913.
40. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
41. Mazan-Mamczarz, K., P. R. Hagner, S. Corl, S. Srikantan, W. H. Wood, K. G. Becker, M. Gorospe, J. D. Keene, A. S. Levenson, and R. B. Gartenhaus. 2008. Post-transcriptional gene regulation by HuR promotes a more tumorigenic phenotype. Oncogene 27:6151-6163.
42. Mazroui, R., S. Di Marco, E. Clair, C. von Roretz, S. A. Tenenbaum, J. D. Keene, M. Saleh, and I. E. Gallouzi. 2008. Caspase-mediated cleavage of HuR in the cytoplasm contributes to pp32/PHAP-I regulation of apoptosis. J. Cell Biol. 180:113-127.
43. Messias, A. C., C. Harnisch, A. Ostareck-Lederer, M. Sattler, and D. H. Ostareck. 2006. The DICE-binding activity of KH domain 3 of hnRNP K is affected by c-src-mediated tyrosine phosphorlyation. J. Mol. Biol. 361:470-481.
44. Moore, M. J. 2005. From birth to death: the complex lives of eukaryotic mRNAs. Science 309:1514-1518.
45. Nakashima, H., G. D. Frank, H. Shirai, A. Hinoki, S. Higuchi, H. Ohtsu, K. Eguchi, A. Sanjay, M. E. Reyland, P. J. Dempsey, T. Inagami, and S. Eguchi. 2008. Novel role of protein kinase C-δ Tyr 311 phosphorylation in vascular smooth muscle cell hypertrophy by angiotensin II. Hypertension 51:232-238.
46. Newbury, S. F., O. Mühlemann, and G. Stoecklin. 2006. Turnover in the Alps: an mRNA perspective. Workshops on mechanisms and regulation of mRNA turnover. EMBO Rep. 7:143-148.
47. Rebane, A., A. Aab, and J. A. Steitz. 2004. Transportins 1 and 2 are redundant nuclear import factors for hnRNP A1 and HuR. RNA 10:590-599.
48. Reyland, M. E. 2007. Protein kinase Cδ and apoptosis. Biochem. Soc. Trans. 35:1001-1004.
49. Sadoshima, J., H. Aoki, and S. Izumo. 1997. Angiotensin II and serum differentially regulate expression of cyclins, activity of cyclin-dependent kinases, and phosphorylation of retinoblastoma gene product in neonatal cardiac myocytes. Circ. Res. 80:228-241.
50. Sandler, H., and G. Stoecklin. 2008. Control of mRNA decay by phosphorylation of tristetraprolin. Biochem. Soc. Trans. 36:491-496.
51. Sengupta, S., B. C. Jang, M. T. Wu, J. H. Paik, H. Furneaux, and T. Hla. 2003. The RNA-binding protein HuR regulates the expression of cyclooxygenase-2. J. Biol. Chem. 278:25227-25233.
52. Schmidlin, M., M. Lu, S. A. Leuenberger, G. Stoecklin, M. Mallaun, B. Gross, R. Gherzi, D. Hess, B. A. Hemmings, and C. Moroni. 2004. The ARE-dependent mRNA-destabilizing activity of BRF1 is regulated by protein kinase B. EMBO J. 23:4760-4769.
53. Schöcklmann, H. O., S. Lang, and R. B. Sterzel. 1999. Regulation of mesangial cell proliferation. Kidney Int. 56:1199-1207.
54. Schreiber, E., P. Matthias, M. M. Müller, and W. Schaffner. 1989. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res. 17:6419.
55. Schulze-Lohoff, E., M. Köhler, H. Fees, N. Reindl, and R. B. Sterzel. 1993. Divergent effects of arginine vasopressin and angiotensin II on proliferation and expression of the immediate early genes c-fos, c-jun and Egr-1 in cultured rat glomerular mesangial cells. J. Hypertens. 11:127-134.
56. Stoecklin, G., T. Stubbs, N. Kedersha, S. Wax, W. F. Rigby, T. K. Blackwell, and P. Anderson. 2004. MK2-induced tristetraprolin:14-13-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J. 23:1313-1324.
57. Sun, L., G. Stoecklin, S. Van Way, V. Hinkovska-Galcheva, R. F. Guo, P. Anderson, and T. P. Shanley. 2007. Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-α mRNA. J. Biol. Chem. 282:3766-3777.
58. Van Der Hoeven, P. C., J. C. Van der Wal, P. Ruurs, and W. J. Van Blitterswijk. 2000. Protein kinase C activation by acidic proteins including 14-3-3. Biochem. J. 347:781-785.
59. Wang, W., M. C. Caldwell, S. Lin, H. Furneaux, and M. Gorospe. 2000. HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation. EMBO J. 19:2340-2350.
60. Yoshida, K., Y. Miki, and D. Kufe. 2002. Activation of SAPK/JNK signaling by protein kinase Cdelta in response to DNA damage. J. Biol. Chem. 277: 48372-48378.
61. Zhang, W., B. J. Wagner, K. Ehrenman, A. W. Schaefer, C. T. DeMaria, D. Crater, K. DeHaven, L. Long, and G. Brewer. 1993. Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1. Mol. Cell. Biol. 13:7652-7665.